Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Elizabeth M. Gore MD
Professor
Department of Radiation Oncology

OFFICE ADDRESS:
Froedtert East Clinics
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
08/1982 - 12/1985 B.A., Northwestern University, Evanston, IL
1986 - 1990 M.D., Medical College of Wisconsin, Milwaukee, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1990 - 1991 Internship, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
1990 - 1994 Residency, Radiation Oncology, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
1994 - 1995 Fellowship, Medical College of Wisconsin, Milwaukee, WI

FACULTY APPOINTMENTS:
07/1994 - 07/1995 Instructor, Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
07/1995 - 02/2003 Assistant Professor of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
03/2003 - 06/2011 Associate Professor of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
07/2011 - Present Professor of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
09/2012 - Present Medical Director, Radiation Oncology, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
1994 - 1997 Consulting Staff, West Allis Memorial Hospital, West Allis, WI
1994 - Present Associate Attending Staff, Froedtert Memorial Lutheran Hospital, Milwaukee, WI
1995 - Present Consulting Staff, Clement Zablocki Veterans Administration, Milwaukee, WI
1995 - Present Faculty Position, Medical College of Wisconsin, Milwaukee, WI
1996 - Present Courtesy Staff, Community Memorial Hospital, Menomonee Falls, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Diplomat, National Board of Medical Examiners
07/1991
None
American Board of Radiology
06/1995
12/31/2021
American Board of Radiology (Re-certification)
09/2000
03/2024
   
Certificates
Issued By Issue DateExpiration
DEA
U.S. Government
10/08/1997
09/30/2024
    

Licensure
Number Issue DateExpiration
Wisconsin
32575-20
08/22/1991
10/31/2023
    

AWARDS AND HONORS:
1993 Resident Essay Award, American Society for Therapeutic Radiology and Oncology (ASTRO)
1993 - 1994 American Cancer Society Fellowship
2008 RTOG Next Generation Investigator, Award Recipient, RTOG 40th Anniversary Celebration
02/09/2017 First Author of an NRG Oncology Outstanding Abstract, NRG Oncology
2020 - Present Fellow, American College of Radiology

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1997 - Present RTOG (Lung Committee)
1997 - 2003 RTOG (Head and Neck Committee)
05/2017 - Present Medical College of Wisconsin Cardiovascular Center (CVC) (Affiliate Member)
International Association for the Study of Lung Cancer (IASLC)
Wisconsin Radiological Society
American Society of Clinical Oncology (ASCO)
American College of Radiology (ACR)
American Society for Therapeutic Radiation Oncology (ASTRO)
Radiation Therapy Oncology Group (RTOG)
Radiological Society of North American (RSNA)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
International Journal of Radiation Oncology Biology and Physics
Geriatric Oncology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1994 - 2003 Palliative Care/Geriatric Oncology Care Committee, Veterans Administration Medical Center (VAMC), Radiation Oncology Representative
1994 - 1997 West Allis Memorial Hospital Radiation Safety Committee, Radiation Oncology Representative
1995 - 2003 Head and Neck Working Group, Medical College of Wisconsin Cancer Center, VAMC Radiation Oncology Representative
1995 - Present Thoracic Tumor Interdisciplinary Study Group, Medical College of Wisconsin Cancer Center
2002 - 2006 Froedtert Memorial Lutheran Hospital Cancer Committee
2005 - 2009 Southeastern Wisconsin Cancer Committee (SEWCC)
2009 - Present Stereotactic Body Radiation Therapy program development, Radiation Oncology Medical College of Wisconsin
2010 - Present Leadership Board of the American Lung Association in Wisconsin (elected position)
2011 - Present Research Member of the Medical College of Wisconsin Cancer Center in the Experimental Therapeutics Research Program (appointed position)
10/2020 - Present Member, Council of Collaboration, Clinical and Translational Science Institute SE Wisconsin (CTSI)
2020 - Present Director, Radiation Oncology Committee to Advance Knowledge & Education Through Clinical Trials (ROCKET), MCW Radiation Oncology Research Program
2020 - Present Chair, Research and Development Committee, Zablocki VA Medical Center

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1999 - Present Member, Lung Cancer Steering Committee, Radiation Therapy Oncology Group (RTOG)
1999 - 2002 Member, Technology Assessment Committee, American Society for Therapeutic Radiation Oncology (ASTRO)
2003 - Present Principal Investigator for Medical College of Wisconsin, Radiation Therapy Oncology Group (RTOG)
2009 - Present Chair i??, Full Member Principal Investigator (FMPI) Committee, RTOG
2010 - Present Lung Cancer Resource Panel, American Society of Therapeutic Radiation Oncology (ASTRO)
2010 - Present Brain Mets Panel, ACR Appropriateness Criteria Radiation Oncology
2011 - Present Publications Committee, Radiation Therapy Oncology Group (RTOG)
2015 - Present Member, Radiation Oncology Field Advisory Committee (ROFAC), National Radiation Oncology Program
2015 - Present Co-chair, New Investigators, NRG Oncology
2016 - Present Co-chair of Radiation Oncology, Publications Committee, NRG Oncology
07/05/2018 - Present Member, Radiation Therapy for Small Cell Lung Cancer Guideline Task Force, ASTRO
10/2020 - Present Member, Clinical Pathways Development Team for Lung Cancer, National Oncology Program Office (NOPO), VHA, Dept. of Veterans Affairs

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Randomized Phase II study of prophylactic cranial versus prophylactic cranial irradiation and consolidative extracranial irradiation in patients with ED-SCLC: RTOG L-0937
Role:
Principal Investigator
Dates:
03/2010 - Present
  
Prior
Peer Review
Title:
Low Dose Rate Irradiation for Human High-grade Glial Tumors
Source:
American Cancer Society
Role:
Principal Investigator
Dates:
07/01/1995 - 06/30/1996
Direct Funds:
$10,000
  
Title:
Phase III study of prophylactic cranial irradiation vs. observation for locally advanced non-small cell lung cancer. Radiation Therapy Oncology Group L-0214
Role:
Principal Investigator
Dates:
2002 - 2007
  
Title:
A Phase II study of a COX2 inhibitor, Celebrex, with limited field radiation for intermediate prognosis patients with locally advanced non-small cell lung cancer with analysis of comorbidity, functional, and psychological status. Radiation Therapy Oncology Group L-0213.
Role:
Principal Investigator
Dates:
2002 - 2004
  
Title:
Evaluation of muscle fatigue in patients receiving radiation therapy for cancer.
Source:
Lance Armstrong Foundation
Role:
Co-Principal Investigator
PI:
Alexander NG, PhD; Marcos Montagninni, MD, Co-Principal Investigator
Dates:
01/2004 - 12/2004
Direct Funds:
$250,000
  
Title:
A Phase II trial of stereotactic Body Radiation Therapy (SBRT) in the treatment of patients with medically inoperable Stage I/II non-small cell lung cancer. RTOG L-0236
Role:
Comorbidity Co-Chair
Dates:
2004 - 2006
  
Title:
A Phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with operable stage I/II non-small cell lung cancer RTOG L-0618
Role:
Comorbidity Co-Chair
Dates:
2007 - 05/2010
  
Non-Peer Review
Title:
Endovascular irradiation to prevent intimal hyperplasia
Source:
Institutional Research Support (MCW)
Role:
Principal Investigator; Julie Freischlag, MD, Co-Investigator; Ricardo Fumagali-Paz, MD, Co-Investigator
Dates:
1996 - 1997
Direct Funds:
$7,493
  
Title:
Phase I/II pilot study of concurrent gemcitabine and accelerated radiation for locally advanced squamous carcinoma of the head and neck.
Source:
Lilly Oncology
Role:
Principal Investigator
Dates:
10/1997 - 11/2001
  
Title:
Phase II feasibility study of a COX2 inhibitor with concurrent radiation therapy of intermediate prognosis patients with locally advanced non-small cell lung cancer.
Source:
Pharmacia Drug Company
Role:
Principal Investigator
Dates:
12/2001 - 12/2003
Direct Funds:
$20,000
  
Title:
A Phase II Study of Preoperative Chemoradiation and Celecoxib Followed by Surgery and Maintenance Celecoxib for Mediastinoscopy-Proven T1-3N2-3M), Stage IIIA/B, Non-Small Cell Lung Cancer (NSCLC)
Source:
Aventis
Role:
Co-Investigator
Dates:
04/2002 - 2005
  
Title:
Phase II trial of Capecitabine and preoperative radiation for rectal cancer.
Source:
Roche
Role:
Principal Investigator
Dates:
2003
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
"Radiation Therapy in the Management of Breast Cancer, " Wisconsin Society of Radiation Therapists of Wisconsin, 03/1998
"Update on therapeutic Strategies for Non-small Cell Lung Cancer: Community Memorial Hospital Continuing Medical Education program, 06/2007
"Stereotactic Body Radiation Therapy", Pulmonary And Critical Care Research Retreat, Clinical Cancer Center, Froedtert Memorial Lutheran Hospital, 02/2010
"Frankly Speaking About Lung Cancer", Workshop, American Lung Association, 12/2013
"Clinical Trials Basics", Lung Force Expo, American Lung Association, Italian Community Center, 05/2015
"Lung Cancer: Understanding the basic principles of non-surgical management of early stage lung cancer", American Lung Association Lung Force Expo, Sheraton Brookfield Hotel, 04/2016
 
Regional
"Comparison between HDR and LDR Dose Distributions for Intravaginal Brachytherapy, " Wisconsin Society of Radiation Oncology, Oconomowoc, Wisconsin, 11/1993
"Advances in Combined Modality Treatment of Locally Advanced Non-small Cell Lung Cancer." Alexian Brothers Hospital, Illinois, 03/1999
"Management of the CNS in Patients with Non-small Cell Lung Cancer." University of Wisconsin Comprehensive Cancer Center Grand Rounds, Madison, Wisconsin, 06/2008
a??Oligometastatic Diseasea??, 51st Annual Southeastern Wisconsin Cancer Conference: Targeting Advanced Lung Cancer, Italian Community Center, Milwaukee, WI, 03/16/2019
 
National
"Pulmonary Function Changes in Long-term Survivors of Bone Marrow Transplantation, " ASTRO, Resident Essay Award, New Orleans, Louisiana, 10/1993
"Comorbidity and Performance Status in Elderly Oncology Patients." Radiation Therapy Oncology Group Semi-annual Meeting, Philadelphia, Pennsylvania, 06/1999
"The role of COX2 inhibitors in the management of lung cancer." Radiation Therapy Oncology Group Semi-annual Meeting, Tampa, Florida, 02/2002
"Basic Principles in Radiation Oncology." Sierra Cascade Trauma Society, Annual Meeting, Crested Butte, Colorado, 03/2002
"Radiation for Lung Cancer in Elderly Patients." American Society of Clinical Oncology (ASCO) Annual Meeting, Orlando, Florida, 05/2005
"Current controversies in locally advanced disease - locally advanced disease: Radiation and systemic therapy - bad prognosis" presented at 10th Annual Perspectives in Thoracic Oncology Conference, New York, NY, 11/2005
"Prophylactic cranial irradiation in extensive disease small cell lung cancer (EORTC 08993-22993)" Keynote Speaker RTOG Semi-Annual Meeting, Philadelphia, Pennsylvania, 06/2007
"Emerging Role of Prophylactic Cranial Irradiation in NSCLC" 5th Annual Atlanta Lung Cancer Symposium, Atlanta, GA, 10/2007
"PCI Update and Implications for Breast Cancer" NCI retreat for strategic plan for the management of brain metastases in breast cancer, Invited Presenter/Participant, 02/2009
"Challenges of mentoring international cooperative group affiliates" RTOG Symposium, Chicago, IL, 06/2009
"Prophylactic Cranial Irradiation for NSCLC and SCLC" 3rd Annual Symposium on Gliomas and Secondary Brain Tumors, Philadelphia, PA, 11/2009
"Brain Metastases: New Therapies, New Insights" 14th Annual Perspective in Thoracic Oncology, New York, NY, 11/2009
"Enrolling Veterans in Clinical Trials", VHA Radiation Oncology Biennial Meeting, San Antonio, TX, 10/19/2018 - 10/20/2018
"Management of Oligometastatic Lung Cancer", AVAHO 2019 Annual Meeting, Hyatt Regency, Minneapolis, MN, 09/20/2019 - 09/22/2019
"Discussion and Strategies on how NRG Can Provide Mentorship to New NCORP Investigators", NRG NCORP Retreat, NRG Philadelphia West Office, Philadelphia, PA, 11/04/2019
 
International
"Radiation Therapy for Elderly Patients" The 9th International Conference on Geriatric Oncology: Cancer in the Elderly. San Francisco, California, 10/2004
"Prophylactic Cranial Irradiation for Non-Small Cell Lung Cancer." Trans-Tansman Radiation Oncology Group (RTOG), Darwin, Australia, 05/2005
"PCI in Locally Advanced NSCLC" 12th World Conference on Lung Cancer, Seoul, Korea, 09/2007
"A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214." ASCO Annual Meeting, Orlando FL, 06/2009
"A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced Non-Small Cell Lung Cancer: 5 Year Update", Chicago Multidisciplinary Symposium in Thoracic Oncology 2012 Plenary Session Presentation abstr #4, ASTRO Annual Meeting 2012 Oral Presentation, Chicago, IL, 09/2012
"NRG Oncology/RTOG 0937: randomized phase II study comparing prophylactic cranial irradiation (PCI) alone to PCI and consolidative extracranial irradiation for extensive small cell lung cancer (EDO-SCLC)" [Oral Presentation], American Society of Therapeutic Radiation Oncology (ASTRO), San Antonio, TX, 10/2015
GORE E, Chen H, Bar Ad V, Robinson C, Wheatley M, Bogart J, Garces Y, Kaadi V, Narayan S, Iyengar P, Witt J, Welsh J, Koprowski C, Larner J, Bradley J., Impact of incidental cardiac radiation on cardiopulmonary toxicity and survival for locally advanced NSCLC: Reanalysis of NRG Oncology/RTOG 0617 with centrally contoured cardiac structures. [Oral Presentation], ASTRO's 58th Annual Meeting, Boston, MA, 09/25/2016 - 09/28/2016
"Controversies in Radiotherapy for SCLC", Meet the Expert Session at IASLC World Conference, Toronto, Canada, 09/23/2018 - 09/26/2018
 

COMMITTEE SERVICE:
Medical College of Wisconsin
1996 - 1997 Clinical Research Committee
1996 - Present Program Development Radiation Therapy for Thoracic Malignancies
1998 - 2007 Faculty Council
2001 - 2004 Admissions Committee
2002 LCME Subcommittee on Governance, Administration and Finance
2006 Comprehensive Internal Review of the MCWAH Ophthalmology Residency Program
2008 - 2011 Member, Women's Faculty Council
2010 Co-Chair, Research Day Committee
2019 - Present Member, Cancer Center Internal Advisory Board
2021 - Present Member, Lung Cancer Search Committee, Froedtert-Medical College of Wisconsin Cancer Center
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Medical Student Education
1994 - Present Clinical Teaching for 3rd and 4th year Medical Student Radiation Oncology elective, Froedtert Memorial Lutheran Hospital/Veterans Administration Medical Center
1997 - 2007 "Radiation Therapy in the Management of Cancer", Yearly Pathology lecture for second year medical students
 
Resident and Fellow Education
1994 - Present Advisor for weekly Radiation Oncology Resident Case Conference, Veterans Administration Medical Center
1994 - Present Staff Resident Clinics at Veterans Administration Medical Center
1994 - Present Clinical rotation for Radiation Oncology Residents
1994 - Present Resident Annual Oral Board Review
1996 - Present Yearly Radiation Oncology Resident and Student Lecture
 
Continuing Medical Education
1989 - Present Radiation Oncology Research Conference, Yearly presentations
03/1998 "Radiation Therapy for Management of Bone Metastases", Pain Resource, Nurse Education Program
12/2000 "Advances in Combined Modality Therapy for Locally Advanced Carcinoma of the Esophagus" First Esophageal Cancer Retreat, Cancer Center
06/2001 "Clinical Trials for Locally Advanced Esophageal Carcinoma" Second Esophageal Cancer Retreat, Cancer Center
10/2003 "Radiation Therapy for Lung Cancer", Division of Pulmonary Medicine
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Residents
Malika Siker, MD, MCW, 2010
Jordan Kharofa, MD, MCW, 2010
 

COMMUNITY SERVICE ACTIVITIES:
1994 - 1995 United Way Representative
1998 - 2000 US Too, Prostate Cancer Support Group, VAMC
09/2003 "Chemotherapy and Radiation for Lung Cancer" FMLH Small Stones Community Lecture
04/2005 American Cancer Society: Sankofa Project First Annual Cancer Education Forum, Milwaukee, WI
03/2006 "Lung cancer updates" presented in the Froedtert Hospital Community Room open to the public
10/2007 "Lung cancer updates" presented in the Froedtert Hospital Community Room open to the public
04/06/2016 Speaker, "Understanding the Basic Principles of Non-surgical Management of Early Stage Lung Cancer", American Lung Association Lung Force Expo, Sheraton Milwaukee Brookfield Hotel, Brookfield, WI
11/16/2017 Opening and Closing Remarks, American Lung Association Lung Force Expo Healthcare Professional Program, Sheraton Milwaukee Brookfield Hotel, Brookfield, WI
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. GORE EM, Gillin MT, Albano K, Erickson B. Comparison of High Dose Rate (HDR) and Low Dose Rate Distributions for Vaginal Cylinders. Int J Radiat Oncol Biol Phys 31(1):165-170, 1995.
2. GORE EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary Function changes in Long-term Survivors of Bone Marrow Transplantation. Int J Radiat Oncol Biol Phys 36:67-75, 1996.
3. Jones R, GORE EM, Meiler W, Murray K, Gillin M, Albano K, Erickson B. Post-treatment Visual Acuity in Patients Treated with Episcleral Plaque Therapy for Choroidal Melanoma: Dose and Dose Rate Effects. Int J Radiat Oncol Biol Phys 52(4):989-995, 2002.
4. Firat S, Bousamra M, GORE EM, Byhardt R. Comorbidity and KPS are independent prognostic factors in Stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 52(4):1047-1057, 2002.
5. Firat S, Byhardt R, GORE EM. Comorbidity and KPS are independent prognostic factors in Stage III non-small cell lung cancer (NSCLC): An institutional analysis of NSCLC patients treated on 4 RTOG studies. Int J Radiat Oncol Biol Phys 54(2):357-64, 2002.
6. GORE EM. Prophylactic cranial irradiation for patients with locally advanced non-small cell lung cancer. Oncology (Huntington) 17(6):775-9, 2003.
7. Regine WF, Schmitt FA, Scott CB, Dearth C, Patchell RA, Nichols RC Jr, GORE EM, Franklin RL 3rd, Suh JH, Mehta MP. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in multi-institutional cooperative group setting: Results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys 58(5):1346-52, 2004.
8. GORE EM, Choy H. Non-small cell lung cancer and standard nervous system metastases: Should we be using prophylactic cranial irradiation? Seminars in Radiation Oncology 14(4):292-297, 2004.
9. Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, GORE EM. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trail of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22(14):2856-64, 2004.
10. GORE EM. Celecoxib and Radiation Therapy for the Treatment of Non-Small-Cell Lung Cancer. Oncology (Williston Park) 18(14 suppl 14):10-14, 2004.
11. Morris DE, Emanmi B, Mauch PM, Konski AA, Tao ML, NG AK, Klein EA,Mohideen N, Hurwitz MD, Fraas BA, Roach M 3rd, GORE EM, Tepper JE. Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiative. Int J Radiat Oncol Biol Phys 62(1):3-19, 2005.
12. GORE EM. RTOG 0214: A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer. Clinical Adv Hematol Oncol 3(8):625-626, 2005.
13. Bradley JD, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, Gore E, Choy H. Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC. J Clin Oncol. 2005 Jun;23(16_suppl):7063.
14. GORE EM. Prophylactic cranial irradiation versus observation in stage III non-small cell lung cancer. Clin Lung Cancer 7(4):276-278, 2006.
15. Li XA, Stepaniak C, GORE EM. Technical and Dosimetric Aspects of Respiratory Gating Using a Pressure-Sensor Motion Monitoring System. Medical Physics 33(1):145-54, 2006.
16. Firat S, Pleister A, Byhardt R, GORE EM. Age is Independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III non-small lung cancer (NSCLC) American Journal of Clinical Oncology 29(3), June, 2006.
17. Contributor: A randomized clinical trial evaluating two doses of prophylactic cranial irradiation in complete responder patients with limited-stage SCLC. The Prophylactic Cranial Irradiation (PCI) Collaborative Group (PCI 99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Lancet Oncology 10(5):467-74, 2009.
18. GORE EM, Choong N, Currey A. Tracheo-esophageal fistula associated with bevacizumab twenty-one months after completion of radiation therapy. Case report. J Thorac Oncol 4(12):1590-1591, 2009.
19. Gore EM, Bae K, Wong S, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Werner-Wasik M, Choy H. A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol. 2009 May 20;27(15_suppl):7506.
20. Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, GORE EM, Choy H. Primary analysis of the Phase II component of a Phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable, non-small cell lung cancer (NSCLC): Radiation Therapy Oncology Group (RTOG) 0117. J Clin Oncol 28(14):2475-2480, 2010.
21. Ulrich CM, Walker EM, James JL, Hartson Stine S, GORE EM, Prestidge B, Michalski JM, Gwede C, Chamberlain R, Watkins Bruner D. RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: Implications for improving recruitment contemporary clinical trials. Contemporary Clinical Trials. May;31(3):221-8, 2010.
22. Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, GORE EM, Choy H. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: Phase I results of RTOG 0117. Int J Radiat Oncol Biol Phys. Jun 1;77(2):367-72, 2010.
23. Stinchcombe TE, GORE EM. Limited-stage small cell lung cancer: Current chemoradiotherapy treatment paradigms. Oncologist. 15(2):187-95, 2010.
24. GORE EM. Non-surgical management of stage I lung cancer. F1000 Medicine Reports. 2, 2010.
25. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, GORE EM, Choy H. Stereotactic body radiation therapy for early stage lung cancer. JAMA 303(11):1070-6, Mar 17,2010.
26. GORE EM, Wong SJ, Bae K, Sun A, Bonner JA, Schild SI, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H. A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer: Primary analysis of Radiation Therapy Oncology Group (RTOG) 0214. J Clin Oncol. 2011 Jan 20;29(3):272-8.
27. Sun A, Bae K, GORE EM, Movsas B, Wong SJ, Meyers CA. A phase III comparison of prophylactic cranial irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer: Neurocognitive and quality of life analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol. Jan 20, 2011:279-286.
28. GORE EM, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H. Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients with locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group (RTOG) 0213. Clinical Lung Cancer. 12(2):125-30, 2011 Mar.
29. Alt CA, Gore EM, Montagnini ML, Ng AV. Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors. Muscle Nerve. 2011 Mar;43(3):415-24.
30. Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011 Oct 05;103(19):1452-60. PMCID: PMC3186782
31. Machtay M, Bae K, Movsas B, Paulus R, GORE EM, Komaki, R, Albain K, Sause WT, Curran WJ. Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 82(1):425-34, 2012 Jan 1.
32. Patel SH, Robbins JR, Gore EM, Bradley JD, Gaspar LE, Germano I, Ghafoori P, Henderson MA, Lutz ST, McDermott MW, Patchell RA, Robins HI, Vassil AD, Wippold FJ 2nd, Videtic GM, Expert Panel on Radiation Oncologya??Brain Metastases. ACR Appropriateness CriteriaA? follow-up and retreatment of brain metastases. Am J Clin Oncol. 2012 Jun;35(3):302-6.
33. Kharofa J, Cohen EP, Tomic R, Xiang Q, Gore E. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Sep 01;84(1):238-43.
34. Gore E, Movsas B, Santana-Davila R, Langer C. Evaluation and management of elderly patients with lung cancer. Semin Radiat Oncol. 2012 Oct;22(4):304-10.
35. Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 2012 Oct 01;84(2):456-63.
36. Kharofa J, Gore E. Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation. Clin Lung Cancer. 2013 May;14(3):283-7.
37. Ahunbay E, Liu F, Bedi M, Gore E, Li X. SU-D-WAB-03: Online Adaptive Stereotactic Body Radiotherapy for Lung Lesions. Med Phys. 2013 Jun;40(6Part3):107.
38. Cury FL, Hunt D, Roach M 3rd, Shipley W, Gore E, Hsu IC, Krisch RE, Seider MJ, Sandler H, Lawton C. Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413. Cancer. 2013 Jun 01;119(11):1999-2004. PMCID: PMC3663874
39. Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, Werner-Wasik M, Sun AY, Choy H, Movsas B. Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):656-64. PMCID: PMC4545268
40. Kachnic LA, Pugh SL, Tai P, Smith M, Gore E, Shah AB, Martin AG, Kim HE, Nabid A, Lawton CA. RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients. Prostate Cancer Prostatic Dis. 2013 Dec;16(4):382-6. PMCID: PMC3830691
41. Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li X. MO-C-17A-06: Online Adaptive Re-Planning to Account for Independent Motions Between Multiple Targets During Radiotherapy of Lung Cancer. Med Phys. 2014 Jun;41(6):415.
42. Yang C, Liu F, Tai A, Gore E, Johnstone C, Li X. SU-E-J-190: Characterization of Radiation Induced CT Number Changes in Tumor and Normal Lung During Radiation Therapy for Lung Cancer. Med Phys. 2014 Jun;41(6):200.
43. Expert Panel on Radiation Oncology-Brain Metastases, Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, Henderson MA, Murad GJ, Patchell RA, Patel SH, Robbins JR, Robins HI, Vassil AD, Wippold FJ 2nd, Yunes MJ, Videtic GM. ACR Appropriateness CriteriaA? pre-irradiation evaluation and management of brain metastases. J Palliat Med. 2014 Aug;17(8):880-6. PMCID: PMC4275774
44. Chen X, Lu H, Tai A, Johnstone C, Gore E, Li XA. Determination of internal target volume for radiation treatment planning of esophageal cancer by using 4-dimensional computed tomography (4DCT). Int J Radiat Oncol Biol Phys. 2014 Sep 01;90(1):102-9.
45. Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S, SIOG Radiotherapy Task Force. Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force. Ann Oncol. 2014 Nov;25(11):2134-2146.
46. Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014 Dec 01;32(34):3858-66. PMCID: PMC4239304
47. Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM. Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. J Clin Oncol. 2015 Feb 01;33(4):332-9. PMCID: PMC4302214
48. Santana-Davila R, Devisetty K, Szabo A, Sparapani R, Arce-Lara C, Gore EM, Moran A, Williams CD, Kelley MJ, Whittle J. Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data. J Clin Oncol. 2015 Feb 20;33(6):567-74. PMCID: PMC4322259
49. Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM. Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Pract Radiat Oncol. 2015 May-Jun;5(3):141-148.
50. Rodrigues G, Choy H, Bradley J, Rosenzweig KE, Bogart J, Curran WJ Jr, Gore E, Langer C, Louie AV, Lutz S, Machtay M, Puri V, Werner-Wasik M, Videtic GMM. Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Pract Radiat Oncol. 2015 May-Jun;5(3):149-155.
51. Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU. Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):863-73. PMCID: PMC4480595
52. Voog JC, Paulus R, Shipley WU, Smith MR, McGowan DG, Jones CU, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Husain SM, Gore E, Raben A, Chafe S, Sandler HM, Efstathiou JA. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08. Eur Urol. 2016 Feb;69(2):204-10. PMCID: PMC4784682
53. Tai A, Liu F, Gore E, Li XA. An analysis of tumor control probability of stereotactic body radiation therapy for lung cancer with a regrowth model. Phys Med Biol. 2016 05 21;61(10):3903-13.
54. Paul J, Gore E, Li X. SU-F-R-54: CT-Texture Based Early Tumor Treatment Response Assessment During Radiation Therapy Delivery: Small Cell Versus Non-Small Cell Lung Cancers. Med Phys. 2016 Jun;43(6):3385.
55. Prior P, Chen X, Johnstone C, Gore E, Li X. SU-F-J-162: Is Bulky Electron Density Assignment Appropriatefor MRI-Only Based Treatment Planning for Lung Cancer? Med Phys. 2016 Jun;43(6):3445.
56. P??choux CL, Sun A, Slotman BJ, De Ruysscher D, Belderbos J, Gore EM. Prophylactic cranial irradiation for patients with lung cancer. Lancet Oncol. 2016 07;17(7):e277-e293.
57. Kachnic LA, Moughan J, Suntharalingam M, Ilson DH, Konski AA, Burrows W, Anker C, Ad VB, Thakrar HV, Hayes JP, Gore EM, Kavadi VS, Komaki RU, Raben A, Giguere JK, Pollock J, Greenberger JS, Videtic GM, Roof KS, Watkins Bruner D. Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S31.
58. Gore EM, Hu C, Ad VB, Robinson CG, Wheatley MD, Bogart JA, Garces Y, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Bradley JD. Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S129-S130.
59. Lim SN, Chen X, Gore EM, Li A. Early Treatment Response Assessment Based on Computed Tomography HU Histogram Feature in the Periphery of Lung Tumors. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E647-E648.
60. Rapp C, Borkenhagen J, Klawikowski S, Rein LE, Gore EM. Risk Factors for Early Radiation-Induced Cardiotoxicity in Lung and Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E429-E430.
61. Borkenhagen J, Rapp C, Klawikowski S, Rein LE, Gore EM. Early Cardiotoxicity in Thoracic Radiation Therapy for Lung and Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E428.
62. Hall WA, Lans D, Arce-Lara C, Kelley MJ, Santana-Davila R, Marcus DM, Tsai S, Ridolfi T, Erickson BA, Gore EM. Outcome Analysis of Treatment in Stage IIA, T3N0 Rectal Adenocarcinoma in the Veterans Health Administration (VHA). Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):E186.
63. Paul J, Gore EM, Li A. Quantitative Computed Tomography for Tumor Response Assessment During Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S193.
64. Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Bahary JP, Patel M, Balogh A, Nabid A, Leibenhaut MH, Hamstra DA, Roof KS, Jeffrey Lee R, Gore EM, Sandler HM, Shipley WU. Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. Urol Oncol. 2016 10;34(10):430.e1-7. PMCID: PMC5035191
65. Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, Li XA. Management of independent motion between multiple targets in lung cancer radiation therapy. Pract Radiat Oncol. 2017 Jan - Feb;7(1):26-34.
66. Xiao C, Zhang Q, Nguyen-T??n PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. Int J Radiat Oncol Biol Phys. 2017 03 15;97(4):667-677. PMCID: PMC5266672
67. Smith ZL, Gonzaga JE, Haasler GB, Gore EM, Dua KS. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer. Dig Dis Sci. 2017 06;62(6):1647-1656.
68. Prior P, Chen X, Gore E, Johnstone C, Li XA. Technical Note: Is bulk electron density assignment appropriate for MRI-only based treatment planning for lung cancer? Med Phys. 2017 Jul;44(7):3437-3443.
69. Paul J, Yang C, Wu H, Tai A, Dalah E, Zheng C, Johnstone C, Kong FM, Gore E, Li XA. Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 06 01;98(2):463-472.
70. Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD. Randomized Phase II Study of Preoperative Chemoradiotherapy A? Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 09;12(9):1413-1420. PMCID: PMC5594738
71. Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937. J Thorac Oncol. 2017 10;12(10):1561-1570. PMCID: PMC5610652
72. Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Rotman M, Gore EM, Balogh AG, McGowan D, Michalski J, Raben A, Rudoler S, Jones CU, Sandler H. Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408. Adv Radiat Oncol. 2017 Oct-Dec;2(4):608-614. PMCID: PMC5707413
73. Gore EM. Select Patients With "Limited" Extensive-Stage Small Cell Lung Cancer Should Be Treated Aggressively. Int J Radiat Oncol Biol Phys. 2018 05 01;101(1):6-7.
74. Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA. Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. Neurosurgery. 2018 05 01;82(5):595-603.
75. Timmerman RD, Paulus R, Pass HI, Gore EM, Edelman MJ, Galvin J, Straube WL, Nedzi LA, McGarry RC, Robinson CG, Schiff PB, Chang G, Loo BW Jr, Bradley JD, Choy H. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial. JAMA Oncol. 2018 09 01;4(9):1263-1266. PMCID: PMC6117102
76. Mostafaei F, Tai A, Gore E, Johnstone C, Haase W, Ehlers C, Cooper DT, Lachaine M, Li XA. Feasibility of real-time lung tumor motion monitoring using intrafractional ultrasound and kV cone beam projection images. Med Phys. 2018 Oct;45(10):4619-4626.
77. Komaki RU, Paulus R, Curran Jr. WJ, Langer CJ, Lee JS, Cox JD, McGarry RC, Werner-Wasik M, Stall BR, Michalski JM, Azawi SH, Hallman MA, GORE EM, Sause WT, Dominello MM, Trochelman RD, Blackstock Jr. AW, Bradley JD. Patterns of Failure According to Tumor Histology and Treatment Schedule in Patients with Locally Advanced Inoperable Non-Small Cell Lung Cancer: Secondary Analysis of NRG Oncology RTOG 9410. Archives of Oncology and Cancer Therapy. 2018;1(2):14-24.
78. Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 11;19(11):1504-1515. PMCID: PMC6540797
79. Konski A, Bhargavan M, Owen J, Komaki R, Langer CJ, Gore E, Paulus R, Choy H, Bruner DW, Curran WJ. An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy. J Radiat Oncol. 2018 Jun;7(2):195-201. PMCID: PMC6294122
80. Sun A, Hu C, Wong SJ, Gore E, Videtic G, Dutta S, Suntharalingam M, Chen Y, Gaspar LE, Choy H. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2019 Jun 01;5(6):847-855. PMCID: PMC6459052
81. Thor M, Deasy JO, Paulus R, Robert Lee W, Amin MB, Bruner DW, Low DA, Shah AB, Malone SC, Michalski JM, Dayes IS, Seaward SA, Gore EM, Albert M, Pisansky TM, Faria SL, Chen Y, Koontz BF, Swanson GP, Pugh SL, Sandler HM. Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415. Radiother Oncol. 2019 06;135:19-24. PMCID: PMC6582638
82. Borkenhagen JF, Bergom C, Rapp CT, Klawikowski SJ, Rein LE, Gore EM. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer. Clin Lung Cancer. 2019 11;20(6):435-441.
83. Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom S, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C. Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study Head and Neck. 2019.
84. Ahunbay E, Liu F, Bedi M, Gore E, li X. SUa??Da??WABa??03: Online Adaptive Stereotactic Body Radiotherapy for Lung Lesions Medical Physics. June 2013;40(6):107.
85. Liu F, Tai A, Ahunbay E, Gore E, Johnstone C, li X. SUa??Ea??CAMPUSa??Ta??01: Dosimetric Benefits of Online Adaptive Replanning for Lung Cancer with Multiple Targets Medical Physics. June 2013;40(6):379.
86. Brinkerhoff BT, Choong NW, Massey BL, Gore EM, Firat SY, Wong SJ, Campbell BH, Schapira RM, Visotcky AM, Tripp PM. Diagnosis to treatment interval and outcome in patients with locally-advanced squamous cell carcinoma of the head and neck in a veterans affairs medical center Journal of Cancer Science and Therapy. 2012;4(5):111-115.
87. Gore E. Prophylactic cranial irradiation in non-small cell lung cancer Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC): Fourth Edition. 13 February 2012:837-844.
88. Tai A, Gore E, li X. THa??Ea??218a??09: Extracting Patienta??Specific Radiobiological Parameters for Radiobiologically Adaptive Radiotherapy Based on Radiation Response for Lung Cancer Medical Physics. June 2012;39(6):4019.
89. Tai A, Gore E, li AX. SUa??Da??BRCa??02: Predicting Individual Lung Tumor Volume Change during Imagea?? Guided Radiation Therapy for Adaptive Radiation Therapy Medical Physics. June 2011;38(6):3384.
90. Tai A, Gore E, Wu S, Li X. SUa??FFa??Ja??101: Is Daily Imagea??Guided Patient Positioning Necessary for Lung Irradiation? Medical Physics. June 2009;36(6):2499.
91. Christensen J, Tai A, Gore E, Li X. SUa??GGa??Ja??02: 3D Lung Tumor Motion Tracking Using MV Conea??Beam CT Acquisition with Synchronized Respiratory Monitoring Medical Physics. June 2008;35(6):2678-2679.
92. Tai A, Christensen J, Gore E, Khamene A, Boettger T, li XA. SUa??GGa??Ja??191: Use of Megavoltage Fluoroscopy and Conea??Beam CT for Ona??Line Verification During 4D/gated Delivery Medical Physics. June 2008;35(6):2723.
93. Semenenko V, Gore E, li X. WEa??Da??M100Ja??05: Estimation of Tumor Control Probability Model Parameters for Early Stage Nona??Smalla??Cell Lung Cancer (NSCLC) Medical Physics. June 2007;34(6):2603.
94. Tai A, Erickson B, Khater K, Gore E, Dias L, li X. SUa??FFa??Ja??93: Respiration Induced Abdominal Organ Motions and Anatomic Changes: Indications for Gated Radiation Therapy Medical Physics. June 2007;34(6):2389-2390.
95. Zhang J, Wu Y, Stepaniak C, Liu W, Gore E, Li X. SUa??FFa??Ja??113: Real Time Tracking of Respiratory Tumor Motion Based On External Respiratory Output Medical Physics. June 2006;33(6):2046.
96. Stepaniak C, Li X, White J, Gore E, Wilson J. SUa??FFa??Ja??125: Thoracic Organ Motion as Assessed by 4D CT: Prone Versus Supine Medical Physics. June 2005;32(6):1949.
97. Stepaniak C, li X, Gore E. SUa??FFa??Ja??113: Determination of Appropriate Lung Volume for Dosimetric Planning and Analysis From 4D CT Medical Physics. June 2005;32(6):1946.
98. Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C. Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study. Head Neck. 2019 11;41(11):3924-3932. PMCID: PMC6865821
99. Simone CB 2nd, Bogart JA, Cabrera AR, Daly ME, DeNunzio NJ, Detterbeck F, Faivre-Finn C, Gatschet N, Gore E, Jabbour SK, Kruser TJ, Schneider BJ, Slotman B, Turrisi A, Wu AJ, Zeng J, Rosenzweig KE. Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2020 May - Jun;10(3):158-173.
100. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement Radiotherapy and Oncology. 2020.
101. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 05;146:223-229. PMCID: PMC7252074
102. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement International Journal of Radiation Oncology Biology Physics. 15 July 2020;107(4):631-640.
103. Thor M, Deasy JO, Hu C, Gore E, Bar-Ad V, Robinson C, Wheatley M, Oh JH, Bogart J, Garces YI, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Xiao Y, Bradley J. Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617. Clin Cancer Res. 2020 09 01;26(17):4643-4650. PMCID: PMC7877447
104. Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. Int J Radiat Oncol Biol Phys. 2020 07 15;107(4):631-640. PMCID: PMC7836268
105. Ibrahim EH, Baruah D, Budde M, Rubenstein J, Frei A, Schlaak R, Gore E, Bergom C. Optimized cardiac functional MRI of small-animal models of cancer radiation therapy. Magn Reson Imaging. 2020 11;73:130-137. PMCID: PMC7530081
106. Chen GP, Tai A, Puckett L, Gore E, Lim S, Keiper T, Johnstone C, Shukla M, Lawton C, Li XA. Clinical Implementation and Initial Experience of Real-Time Motion Tracking With Jaws and Multileaf Collimator During Helical Tomotherapy Delivery. Pract Radiat Oncol. 2021 Sep-Oct;11(5):e486-e495.
107. Ibrahim EH, Baruah D, Croisille P, Stojanovska J, Rubenstein JC, Frei A, Schlaak RA, Lin CY, Pipke JL, Lemke A, Xu Z, Klaas A, Brehler M, Flister MJ, Laviolette PS, Gore EM, Bergom C. Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model. JACC CardioOncol. 2021 Mar;3(1):113-130. PMCID: PMC8078846
108. Ibrahim EH, Frank L, Baruah D, Arpinar VE, Nencka AS, Koch KM, Muftuler LT, Unal O, Stojanovska J, Rubenstein JC, Brown SA, Charlson J, Gore EM, Bergom C. Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging. Int J Biomed Imaging. 2021;2021:8851958. PMCID: PMC8147553
109. Aqeel M, Medhora M, Gore E, Borkenhagen J, Klawikowski S, Eastwood D, Banerjee A, Jacobs ER. Evaluation of Radiation-induced Pleural Effusions after Radiotherapy to Support Development of Animal Models of Radiation Pneumonitis. Health Phys. 2021 10 01;121(4):434-443. PMCID: PMC8500166
110. Schottstaedt AM, Paulson ES, Rubenstein J, Chen X, Omari E, Li A, Gore EM, Schultz CJ, Hall WA. Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e75-e76.
111. Noid G, Tai A, Zhong H, Shah J, Gore EM, Li A. Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e128.
112. Movsas B, Rodgers J, Elshaikh MA, Martinez AA, Morton G, Krauss DJ, Yan D, Citrin DE, Hershatter B, Michalski JM, Ellis RJ 3rd, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker V, Olson AC, Karrison TG, Sandler HM, Bruner DW. Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):S3.
113. Cooper B, Bedi M, Bovi JA, Currey AD, Erickson BA, Gore EM, Hall WA, Lawton CAF, Schultz CJ, Siker ML, Saeed H. Enhancing Patient-Physician Experience in the Digital Era: A Review of Mobile Health Applications for Oncology Patients. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e105-e106.
114. Noid G, Tai A, Zhong H, Shah J, Gore EM, Li A. Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e128.
115. Movsas B, Rodgers J, Elshaikh MA, Martinez AA, Morton G, Krauss DJ, Yan D, Citrin DE, Hershatter B, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker V, Olson AC, Karrison TG, Sandler HM, Bruner DW. Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial International journal of radiation oncology, biology, physics. 1 November 2021;111(3):S3.
116. Schottstaedt AM, Paulson ES, Rubenstein J, Chen X, Omari E, Li A, Gore EM, Schultz CJ, Hall WA. Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e75-e76.
117. Cooper B, Bedi M, Bovi JA, Currey AD, Erickson BA, Gore EM, Hall WA, Lawton CAF, Schultz CJ, Siker ML, Saeed H. Enhancing Patient-Physician Experience in the Digital Era: A Review of Mobile Health Applications for Oncology Patients. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e105-e106.
118. Cooper B, Bedi M, Bovi JA, Currey AD, Erickson BA, Gore EM, Hall WA, Lawton CAF, Schultz CJ, Siker ML, Saeed H. Enhancing Patient-Physician Experience in the Digital Era: A Review of Mobile Health Applications for Oncology Patients. Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e105-e106.
119. Noid G, Tai A, Zhong H, Shah J, Gore EM, Li A. Lung Perfused Blood Volume Calculated From Dynamic Contrast Enhanced DECT for Radiation Treatment Planning of Lung Cancer International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e128.
120. Movsas B, Rodgers J, Elshaikh MA, Martinez AA, Morton G, Krauss DJ, Yan D, Citrin DE, Hershatter B, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker V, Olson AC, Karrison TG, Sandler HM, Bruner DW. Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial International journal of radiation oncology, biology, physics. 1 November 2021;111(3):S3.
121. Schottstaedt AM, Paulson ES, Rubenstein J, Chen X, Omari E, Li A, Gore EM, Schultz CJ, Hall WA. Development of a Comprehensive Cardiac MRI Atlas of Half Fourier-Acquired Single-Shot Turbo Spin-Echo (HASTE) and 3D Balanced Steady-State Free Precession (bSSFP) Sequences Prospectively Acquired From a 1.5T MR-Linac International journal of radiation oncology, biology, physics. 1 November 2021;111(3):e75-e76.
122. Hall WA, Karrison TG, Rosenthal SA, Amin MB, Gomella LG, Purdy JA, Sartor AO, Michalski JM, Garzotto MG, Bergom C, Jani AB, Lawton CAF, Simko JP, Moore JK, Gore EM, Lee WR, Nguyen PL, Danielson BL, Sandler HM, Feng FY. The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521. Int J Radiat Oncol Biol Phys. 2022 Oct 01;114(2):266-274. PMCID: PMC9444930
123. Stinchcombe TE, Gore EM. Neurotoxicity Related to Radiotherapy and Chemotherapy for Nonsmall Cell and Small Cell Lung Cancer IASLC Thoracic Oncology. 1 January 2018:409-417.e2.
 
Books, Chapters, and Reviews
1. GORE, E.M. & Wong, S. (1997). Stage IIE Non-Hodgkin's Lymphoma of the Oropharynx: Radiotherapy versus Chemotherapy versus Both. In D.P. Winchester & M.F. Brennan & G.D. Dodd & D.E. Henson & B.J. Kennedy & G.D. Steele & J.F. Wilson (Eds.), Tumor Board Case Management (pp. 682-684). Philadelphia, PA: Lippincott-Raven.
2. GORE, E.M. & Byhardt, R.W. (2001). Surgery for Potentially/Marginally Resectable Pathologic N2 NSCLC. In B. Movsas & C. Langer & M. Goldberg (Eds.), Controversies and Issues in Lung Cancer (pp. 213-224). New York, NY: Marcel Dekker, Inc.
3. Ng, A.V. & Alt, C.A. & GORE, E.M. (2007). Fatigue. In M. Feuerstein (Ed.), Handbook of Cancer Survivorship (pp. 133-150). New York, NY: Springer.
4. GORE, E.M. (2009). Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer. In H. Pass & D. Carbone & D. Johnson & J. Minna & A. Turrisi & V. Scagliotti (Eds.), Lung Cancer: Principles and Practice 4th Edition (pp. 837-844). Baltimore, MD: Lippencott, Williams and Wilkin.
5. Menon, S.P. & GORE, E.M. (2017). Management of Locally Advanced Non-Small-Cell Lung Cancer. In G.P. Kalemkerian & J.S. Donington & E.M. Gore & S.S. Ramalingam (Eds.), Handbook of Lung Cancer and Other Thoracic Malignancies (pp. 131-156). New York, NY: Demos Medical.
6. Kalemkerian, G.P. & Donington, J.S. & GORE, E.M. & Ramalingam, S.S. (2017) Handbook of lung cancer and other thoracic malignancies. New York, NY: Demos Medical.
7. Saeed H & Shukla M & GORE E (2021). Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer. In Advances in Radiation Oncology in Lung Cancer. Branislav Jeremic. Springer
 
Editorials, Letters to Editor, Other
1. Firat S, GORE EM, Byhardt R. Do "elderly fit" patients have less comorbidity? Int J Radiat Oncol Biol Phys, 55(5):1166-1168, 2003.
2. GORE EM. Brain Metastases in Very Young Patients with Lung Cancer Are Still Brain Metastases. Onkologie (6): 297-8, June 31, 2008.
3. GORE EM. "Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Lung Cancer" F1000 Medicine Reports, January, 2010.
4. Choong NW, GORE EM. Stereotactic Radiosurgery for the Management of Brain Metastases. N Engl J Med, 363(6):591-593, August 5, 2010.
5. Expert reviewer (invited) - ASTRO Evidence-Based Guideline on Palliative Thoracic Radiotherapy in Lung Cancer. October, 2010.
 
Abstracts
1. GORE EM, Lipchik RJ, Ash RC, Lawton CA. Pulmonary function changes in long-term survivors of bone marrow transplantation. 35th Annual ASTRO Meeting, New Orleans, LA, October, 1993. Int J Radiat Oncol Biol Phys Proceedings of the American Society of Therapeutic Radiology and Oncology 35th Annual Meeting, 27:S1, 185, 1993.
2. Bruner DW, Scott CB, McGowan D, Lawton C, Hanks G, Prestidge B, Gaspar L, GORE EM, Asbell A. RTOG: Validation for the Sexual Adjustment Questionnaire (SAQ) in Prostate Cancer Patients Enrolled in RTOG Studies 90-20 and 94-08. Presented at the 40th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, Phoenix AZ, Int J Radiat Oncol Biol Phys 42(1) #156, 202, 1998.
3. Garden A, Pajak T, Vokes E, Forastiere A, Ridge J, Jones C, Horwitz E, Glisson B, Nabell L, Cooper J, Demas W, GORE EM. Preliminary results of RTOG 9703 - A Phase II Randomized Trial of Concurrent Radiation (RT) and Chemotherapy for Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck. Presented at Annual Meeting American Society of Clinical Oncology, May 2001.
4. Regine W, Schmitt F, Scott C, Dearth C, Patchell R, Nichols R, GORE EM, Franklin F, Suh J, Mehta M. Feasibility of Neurocognitive Outcome Evaluations in Patients with Brain Metastases in a Multi-Institutional Cooperative Group Setting: Results of Radiation Oncology Therapy Group (RTOG) Trial BR-0018. Presented at the American Society of Therapeutic Radiation and Oncology, 2002.
5. GORE, EM. Phase II feasibility study of COX-2 inhibitor with concurrent radiation therapy for intermediate prognosis patients with LA-NSCLC. Presented at The University of Texas MD Anderson Cancer Center Investigators' Workshop, Amelia Island, FL July 16-20, 2003.
6. Wong SJ, Sadasiwan C, Erickson B, Ota D, Mulkerin D, Thomas J, Holen K, Meadows S, Ritch P, Telford G, Redlich P, GORE EM. A phase II trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer. Presented at Annual Meeting American Society of Clinical Oncology, June, 2004.
7. Firat S, Pleister A, Byhardt R, GORE EM. Comorbidity is an independent factor influencing patient selection for combined modality therapy for treatment of a stage III non-small cell lung cancer (NSCLC). Presented at the 46th Annual ASTRO Meeting, October 2004, Atlanta, GA.
8. Bradley JD, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, GORE EM, Choy H. Phase I results of RTOG L0117; A phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC. Presented at 2005 ASCO Annual Meeting, May 2005, Orlando, FL.
9. Ng AV, Alt C, GORE E, Jablonski K, Montagnini M, Stern J, Dufek S. Mechanisms of fatigue in cancer survivors. Medicine & Science in Sports & Exercise: Abstract Issue, Vol 38(5)Suppl; S82; May, 2006.
10. Bradley JD, Graham MV, Moughan J, Byhardt R, Govindan R, Fowler J, Purdy J, Mihchalski J, GORE EM, Choy H. Phase I/II results of RTOG L-0117; A Phase I/II Dose Intensification Study Using 3DCRT and Concurrent Chemotherapy for Patients with inoperable NSCLC. Abstract PD-2-4, p. S476. 12th World Conference on Lung Cancer, Seoul, Korea, September 2-6, 2007.
11. GORE EM, Bae K, Wong S, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Werner-Wasick M, Choy H. A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol 27:15s, 2009 (suppl; abstr 7506).
12. GORE EM, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H. Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients with locally advanced non-small cell lung cancer: Radiation Oncology Group (RTOG) 0213. World Conference Lung Cancer, 2009, poster presentation. J Thorac Oncol 4:9s, 2009 (suppl; abstr P3.016).
13. Sun A, Bae K, GORE EM, Wong S, Meyers C, Movsas B, Bonner J, Schild S, Gaspar L, Bogart J, Werner-Wasik M, Choy H. A Phase III Comparison of prophylactic cranial Irradiation (PCI) versus observation in patients with locally advanced non-small cell lung cancer (LA-NSCLC). Initial analysis of primary and secondary endpoints: RTOG 0214. J Thorac Oncol 4:9s, 2009 (suppl; abstr C6.6).
14. Movsas B, Bae K, Meyers C, GORE EM, Bonner J, Sun A, Schild S, Gaspar LE, Bogart J, Choy H. Phase III study of prophylactic cranial irradiation (PCI) versus observation in patients with stage III non-small cell lung cancer (NSCLC): Neurocognitive and quality of life (QOL) analysis of RTOG 0214. Int J Radiat Oncol Biol Phys 75:3s, 2009 (suppl; abstr 2).
15. Bradley JD, Bae K, Graham M, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski J, GORE EM, Choy H. Initial primary analysis of Phase II for RTOG 0117: A Phase I/II dose intensification study using three dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable, non-small cell lung cancer (NSCLC). J Thorac Oncol 4:9s, 2009 (suppl; abstr B5.2).
16. Tai A, GORE EM, Li XA. Analyzing dose response of stereotactic body radiation therapy for lung tumors with a modified linear quadratic model. Int J Radiat Oncol Biol Phys 75:3s, 2009 (suppl; abstr 2958).
17. Cury F, Hunt d, Roach M, Lawton C, GORE EM, Hsu I, Krisch RE, Seider MJ, Sandler H, Shipley WU. PSA response after short-term hormonal therapy plus external beam radiotherapy and outcome in patients treated on RTOG 9413. Int J Radiat Oncol Biol Phys Volume 78(3), Suppl 1; S124, November 2010.
18. Suntharalingam M, Paulus R, Edelman MH, Krasna M, Burrows W, GORE EM, Yom SS, Choy H. RTOG 0229: A phase II trial of neoadjuvant therapy with concurrent chemotherapy and high dose radiotherapy (XRT) followed by resection and consolidative therapy for LA-NSCLC. Int J Radiat Oncol Biol Phys Volume 78(3), Suppl 1; S111, November 2010.
19. Alt CA, GORE EM, Montagnini ML, Ng AV. Muscle Endurance, Cancer-Related Fatigue, and Radiotherapy in Prostate Cancer Survivors. Muscle Nerve. 43:415-424, 2011.
20. Gondi V, Paulus R, Bruner DW, Meyers CA, GORE EM, Wolfson A, Werner-Wasik M, Choy H, Movsas B. Prognostic significance of QOL Deterioration during early lung cancer survivorship: Secondary analysis of RTOG 0212 and 0214. J Clin Oncol. 2011;29(15; May 20 suppl):abstr 6061.
21. Edelman MJ, Paulus R, Suntharalingam M, Krasna M, Burrows W, GORE EM, Yom SS, Choy H. RTOG 0229: A phase II trial of concurrentchemotherapy and full dose radiotherapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. J Thorac Oncol 6(6), Suppl 1; S375-376, June 2011.
22. Kong (Spring) FM, Xiao Y, Machtay M, Werner-Wasik M, Videtic GM, Loo BW, Wagner H, GORE EM, Varlotto J, Faria S, Dilling TJ, Sun A, Swanson T, Wang L, Galvin J, Ten Haken RK, Bradley J. Using During-RT PET to individualize adaptive RT for patients with Stage III NSCLC: A multicenter planning study. J Thorac Oncol. 2011; 6(6;suppl 2): S834-835.
23. Choong N, Siker M, Suboc T, Devisetty K, Foy P, GORE EM. Incidence and impact syndrome of inappropriate anti-diuretic hormone hypersecretion(SIADH) in small cell lung cancer (SCLC). J Thorac Oncol 6(6), Suppl 2; S1341-1342, June 2011.
24. Devisetty K, Siker M, Suboc T, Choong N, GORE EM. Extensive stage small cell lung cancer: Metastatic presentation, progression, and implications for oligometastatic treatment. J Thorac Oncol 6(6), Suppl 2; S1343, June 2011.
25. GORE EM, Gasparri M, Devisetty K, Choong N, Tisol W, Haasler G. Pulmonary resection after high dose radiation therapy (>59 Gy) and concurrent chemotherapy for non-small cell lung cancer. J Thorac Oncol 6(6), Suppl 2; 1558, June 2011.
26. Siker ML, Devisetty K, Suboc T, Choong NW, GORE EM. Extensive stage small cell lung cancer: Patterns of failure after chest and cranial radiotherapy. Int J Radiat Oncol Biol Phys 81(2), S135-136, October 2011.
27. Devisetty K, Siker ML, Suboc T, Choong NW, GORE EM. Pattern and extent of failure in limited stage small cell lung cancer: Implications for oligometastatic treatment. Int J Radiat Oncol Biol Phys 81(2), S584, October 2011.
28. Kharofa JR, Cohen E, Tomic R, Xiang Q, GORE EM. Antiotensin converting enzyme inhibitor mitigation of radiation pneumonitis. Int J Radiat Oncol Biol Phys 81(2), S602-603, October 2011.
29. Kong FP, Machtay M, Videtic G, Loo BW, GORE EM, Wagner H, Varlotto J, Faria S, Dilling TJ, Sun A. Using during RT PET to individualize adaptive RT for patients with Stage III NSCLC: A RTOG planning study. Int J Radiat Oncol Biol Phys 81(2), S603, October 2011.
30. Gondi V, Paulus R, Bruner DW, Meyers CA, GORE EM, Wolfson A, Werner-Wasik M, Choy H, Movsas B. Decline in tested and patient-reported cognitive functioning following prophylactic cranial irradiation for lung cancer: Secondary analysis of RTOG 0212 and 0214. Int J Radiat Oncol Biol Phys 81(2), S50, October 2011.
31. Krauss DJ, Hunt D, Bahary J, Souhami L, GORE E, Chafe S, Leibenhaut M, Narayan S, McGowan D, Jones C. Inferior Clinical Outcomes for Patients with Positive Post-Radiation Therapy Prostate Biopsy: Results from Prospective Randomized Trial RTOG 94-08. Int J Radiat Oncol Biol Phys 87(25), S54, October 2013.
32. Yang C, Liu F, GORE E, Li XA. Dose-Dependent CT Number Changes in Both Tumor and Normal Lung Observed During Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys 87(25), S3284, October 2013.
33. Wheatley MD, GORE EM, Bar Ad V, Robinson CG, Bradley JD. Defining a Novel Cardiac Contouring Atlas for NSCLC Using Cadaveric Anatomy. Int J Radiat Oncol Biol Phys 90(1), S658, September 2014.
34. Tai A, Prior P, Gore E, Johnstone C, Li X SU-E-J-31: Monitor Interfractional Variation of Tumor Respiratory Motion Using 4D KV Conebeam Computed Tomography for Stereotactic Body Radiation Therapy of Lung Cancer. Med Phys. 2015 Jun;42(6):3270
35. Yu J, Gong Y, Bar-Ad V, Giaddui T, Hu C, Gore E, Wheatley M, Witt J, Robinson C, Kong F, Bradley J, Galvin J, Xiao Y SU-E-J-134: Optimizing Technical Parameters for Using Atlas Based Automatic Segmentation for Evaluation of Contour Accuracy Experience with Cardiac Structures From NRG Oncology/RTOG 0617. Med Phys. 2015 Jun;42(6):3295
36. Straza MW, Currey A, Firat S, Santana-Davila R, Menon S, GORE E. The Safety and Efficacy of Thoracic Reirradiation. Journal of Thoracic Oncology. 2015 Sept; 10(9):S652
37. GORE EM, Hu C, Sun A, Grimm D, Ramalingam S, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone C, Atkins JN, Bradley JD. NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC). Int J Radiat Oncol Biol Phys 2016 Jan; 94 (1):5
38. GORE EM, Hu C, Ad VB, Robinson CG, Wheatley MD, Bogart JA, Garces Y, Kavadi VS, Narayan S, Iyengar P, Witt JS, Welsh JW, Koprowski CD, Larner JM, Bradley JD. Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 with Centrally Contoured Cardiac Structures. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S129-S130.
39. Voog JC, Paulus R, Shipley WU, Smith MR, McGowan DG, Jones CU, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, Husain SM, GORE E, Raben A, Chafe S, Sandler HM, Efstathiou JA. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-98. Eur Urol 2016 Feb;69(2):204-10
40. Tai A, Liu F, GORE E, Li XA. An Analysis of Tumor Control Probability of Stereotactic Body Radiation Therapy for Lung Cancer with a Regrowth Model. Phys Med Biol. 2016 May 21;61(10):3903-13
41. Pechoux CL, Sun A, Slotman BJ, De Ruysscher D, Belderbos J, GORE EM. Prophylactic Cranial Irradiation for Patients with Lung Cancer. Lancet Oncol. 2016 Jul;17(7):e277-93
42. Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Bahary JP, Patel M, Balogh A, Nabid A, Leibenhaut MH, Hamstra DA, Roof KS, Jeffrey Lee R, GORE EM, Sandler HM, Shipley WU. Acute and Late Urinary Toxicity Following Radiation in Men with an Intact Prostate Gland or After a Radical Prostatectomy: A Secondary Analysis of RTOG 94-08 and 96-01. Urol Oncol. 2016 Oct;34(10):430.e1-7
43. Liu F, Tai A, Ahunbay E, GORE E, Johnstone C, Li XA. Management of Independent Motion between Multiple Targets in Lung Cancer Radiation Therapy. Pract Radiat Oncol. 2017 Jan-Feb;7(1):26-34
44. Xiao C, Zhang Q, Nguyen-Tan PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, GORE E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D. Quality of Life and Performance Status from a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Verus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):667-677
45. Prior P, Chen X, GORE E, Johnstone C, Li XA. Technical Note: Is Bulk Electron Density Assignment Appropriate for MRI-only Based Treatment Planning for Lung Cancer? Med Phys. 2017 Apr 9 [Epub ahead of print]
46. Smith ZL, Gonzaga JE, Haasler GB, GORE EM, Dua KS. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer. Dig Dis Sci. 2017 Jun;62(6):1647-1656
47. Paul J, Yang C, Wu H, Tai A, Dalah E, Zheng C, Johnstone C, Kong FM,, GORE E, Li XA. Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):463-472
48. Hall WA, Karrison TG, Rosenthal SA, Amin M, Gomella LG, Purdy JA, Sartor O, Michalski JM, Garzotto M, Bergom C, Jani A, Lawton CAF, Simko J, Moore J, GORE EM, Lee WR, Nguyen PL, Danielson B, Sandler HM, Feng FY. The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521. Int J Radiat Oncol Biol Phys. 2018 Nov;102(3):S13-S14